Evaluation Of The Impact Of A Call Center In Management Of Metastatic And/Or Advanced Renal Cell Carcinoma Patients Treated With Sunitinib (Sutent) In First Line

NCT02187042 · clinicaltrials.gov ↗

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic/Advanced Renal Cell Carcinoma

Interventions

OTHER: Best supportive care
OTHER: call center

Sponsor

Pfizer